Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

eMI Aesthetics vs RxPros

eMI Aesthetics
Graded #113

Higher grade

vs+1
RxPros
Graded #138

Lower grade

The verdict

eMI Aesthetics takes it — 70.1/100 to 69.1/100, but only just.

eMI Aesthetics grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. eMI Aesthetics is a US direct-to-consumer telehealth brand offering doctor-guided GLP-1 weight loss programs to eligible patients in all 50 states. RxPros is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueeMI Aesthetics +2
72
70
Dose & formulationeMI Aesthetics +20
84
64
Clinical oversightRxPros +21
70
91
Labs & monitoringRxPros +2
51
53
FulfillmenteMI Aesthetics +3
77
74
Contract termseMI Aesthetics +8
55
47
eMI Aesthetics · left barRxPros · right bar

The numbers

MetriceMI AestheticsRxPros
WeighScore70.1/10069.1/100
GradeCC
Scorecard rank#113#138
Semaglutide$179/mo (all doses, compounded)$100/mo (annual plan, compounded)
TirzepatideNot disclosed$145/mo (annual plan, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
eMI Aesthetics

Graded #113 · C

Strengths

  • Available to eligible patients in all 50 states
  • Offers both semaglutide and tirzepatide, plus an oral semaglutide option
  • Intake and provider visits run through OpenLoop Health, an established telehealth network

Where it loses points

  • Full per-drug pricing is not shown before intake; only an 'as low as 179/month' starting rate is published
  • No fill pharmacy or named medical director is publicly listed
  • Support appears limited to email, with no phone number or hours published
RxPros

Graded #138 · C

Strengths

  • $99.99/month compounded semaglutide — among the cheapest in the US compounded telehealth market
  • $144.97/month compounded tirzepatide — at the lower end of the compounded tirzepatide range
  • LegitScript Certified
  • Named legal entity (RxPros LLC) with a physical Wyoming address
  • Overnight cold-packed shipping disclosed — important for GLP-1 cold-chain integrity

Where it loses points

  • Per-state availability not listed — verify your state ships before committing
  • Specific 503A pharmacy partners not named
  • Lab work not included as standard
  • LegitScript certification number not displayed (seal only)
  • Lowest headline prices ($99.99 sema / $144.97 tirz) require annual prepay; intro-first-month/quarterly tier is $134.99 sema / $224.99 tirz

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard